Researcher Profile
Lee, Dong Chul(이동철)
83
Genomic Medicine Research Center (유전체맞춤의학연구센터)
- Tel042-879-8153
- Technology
- Research Keywords
- Cancer biology ; Cancer metabolism ; Oncology
- 암생물학 ; 암대사 ; 항암제
Keywords Cloud
KRIBB Co-Working
Results 1-20 of 83 (Search time: 0.002 seconds).
| No. | Year | Title | Type |
|---|---|---|---|
| 83 | 2025 | 2025Article Anti-proteolytic regulation of KRAS by USP9X/NDRG3 in KRAS-driven cancer developmentNature Communications, vol. 16, pp. 628-628Han Koo; Kyung Chan Park; Hyun Ahm Sohn; Minho Kang; D J Kim; Z Y Park; S Park; S H Min; Seong-Hwan Park; Yeon Mi You, et al. |
Article |
| 82 | 2025 | 2025Article PEG-coated ceria-zirconia nanoparticle prevent weight gain and obesity-related organ damage through autophagy flux activation and ROS scavengingInternational Journal of Nanomedicine, vol. 20, pp. 8305-8326E K Kim; S E Hong; Y S Choi; S L Yu; J Kang; C G Park; H Y Lee; S K Lee; Dong Chul Lee; W M Hwang, et al. |
Article |
| 81 | 2025 | 2025Article Exosomal miR-203a-3p enhances endometrial receptivity by upregulating E-cadherin expression through the direct targeting of SNAI1 in endometrial epithelial cellsReproductive Medicine and Biology, vol. 24, pp. e12689-e12689S L Yu; H Lee; J Park; M Song; Dong Chul Lee; T H Kim; S K Lee; A R Han; J Kang; S R Park |
Article |
| 80 | 2025 | 2025Research Project KRAS 안정성 조절인자 NDRG3 표적화 췌장암 제어용 이중기능성 유효/선도물질 도출연구책임자 : 이동철 / 사업기간 : 2025.01.01 ~ 2025.04.30 |
Research Project |
| 79 | 2025 | 2025Research Project 단백질 안정화 분자기전 표적화 췌장암 치료법 개발연구책임자 : 이동철 / 사업기간 : 2025.03.01 ~ 2026.02.28 |
Research Project |
| 78 | 2025 | 2025Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 김선영 / 사업기간 : 2025.01.01 ~ 2025.12.31 |
Research Project |
| 77 | 2024 | 2024Patent 벤즈이미다졸 유도체를 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물KR10-2021-0113677 (2021.08.27) / 10-2740381 (2024.12.04)염영일; 이동철; 박경찬; 구한; 김차연 |
Patent |
| 76 | 2024 | 2024Patent 신규한 피리미딘-4-온 화합물 및 이를 포함하는 항암제 조성물KR10-2021-0095927 (2021.07.21) / 10-2649886 (2024.03.18)염영일; 박경찬; 이동철 |
Patent |
| 75 | 2024 | 2024Article Exosomal miR-196b secreted from bronchial epithelial cells chronically exposed to low-dose PM2.5 promotes invasiveness of adjacent and lung cancer cellsToxicology Letters, vol. 399, pp. 9-18S L Yu; Han Koo; Y Kang; H J Jeon; Minho Kang; D H Choi; S Y Lee; J W Son; Dong Chul Lee |
Article |
| 74 | 2024 | 2024Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2024.01.01 ~ 2024.12.31 |
Research Project |
| 73 | 2024 | 2024Research Project 단백질 안정화 분자기전 표적화 췌장암 치료법 개발연구책임자 : 이동철 / 사업기간 : 2024.03.01 ~ 2025.02.28 |
Research Project |
| 72 | 2024 | 2024Research Project KRAS 안정성 조절인자 NDRG3 표적화 췌장암 제어용 이중기능성 유효/선도물질 도출연구책임자 : 이동철 / 사업기간 : 2024.01.01 ~ 2024.12.31 |
Research Project |
| 71 | 2024 | 2024Article PEG-capped ceria-zirconia nanoparticles improved renal fibrosis in cellular and animal models of fabry diseaseACS Applied Nano Materials, vol. 7, no. 3, pp. 2913-2928E K Kim; S E Hong; Y Li; S L Yu; Y S Choi; J Kang; C G Park; H Y Lee; S K Lee; Dong Chul Lee, et al. |
Article |
| 70 | 2023 | 2023Article Regulating POLR3G by microRNA-26a-5p as a promising therapeutic target of lung cancer stemness and chemosensitivityNon-coding RNA Research, vol. 8, no. 3, pp. 273-281C R Park; M Lee; S Y Lee; D Kang; S J Park; Dong Chul Lee; Han Koo; Y G Park; S L Yu; I B Jeong, et al. |
Article |
| 69 | 2023 | 2023Research Project KRAS 안정성 조절인자 NDRG3 표적화 췌장암 제어용 이중기능성 유효/선도물질 도출연구책임자 : 이동철 / 사업기간 : 2023.01.01 ~ 2023.12.31 |
Research Project |
| 68 | 2023 | 2023Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2023.01.01 ~ 2023.12.31 |
Research Project |
| 67 | 2023 | 2023Research Project 단백질 안정화 분자기전 표적화 췌장암 치료법 개발연구책임자 : 이동철 / 사업기간 : 2023.03.01 ~ 2024.02.29 |
Research Project |
| 66 | 2023 | 2023Article Exosomal miR-205-5p improves endometrial receptivity by upregulating E-cadherin expression through ZEB1 inhibitionInternational Journal of Molecular Sciences, vol. 24, no. 20, pp. 15149-15149S L Yu; D U Jeong; E J Noh; H J Jeon; Dong Chul Lee; Minho Kang; T H Kim; S K Lee; A R Han; J Kang, et al. |
Article |
| 65 | 2022 | 2022Article Ceria-Zirconia nanoparticles reduce intracellular globotriaosylceramide accumulation and attenuate kidney injury by enhancing the autophagy flux in cellular and animal models of Fabry diseaseJournal of Nanobiotechnology, vol. 20, pp. 125-125J H An; S E Hong; S L Yu; J Kang; C G Park; H Y Lee; S K Lee; Dong Chul Lee; H W Park; W M Hwang, et al. |
Article |
| 64 | 2022 | 2022Article LPIN1 induces gefitinib resistance in EGFR inhibitor-resistant non-small cell lung cancer cellsCancers, vol. 14, no. 9, pp. 2222-2222Jung Hee Cho; Yeon Mi You; Han Koo; Dong Chul Lee; Young Il Yeom; Kyung Chan Park |
Article |